Oak Grove Capital’s Pfizer PFE Stock Holding History

Oak Grove Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,400	Closed	-$220K	–	60
2023 Q1	$220K	Sell	5,400 -252	-4%	-$10.9K	0.09%	51
2022 Q4	$290K	Sell	5,652 -7,200	-56%	-$345K	0.15%	45
2022 Q3	$562K	Hold	12,852	–	–	0.19%	43
2022 Q2	$674K	Sell	12,852 -15,300	-54%	-$780K	0.22%	43
2022 Q1	$1.46M	Hold	28,152	–	–	0.3%	40
2021 Q4	$1.66M	Sell	28,152 -9,000	-24%	-$446K	0.29%	51
2021 Q3	$1.6M	Buy	37,152 +17,152	+86%	+$760K	0.35%	49
2021 Q2	$783K	Buy	+20,000	New	+$778K	0.18%	62

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oak Grove Capital's PFE Position: Q2 2023 in Review

Oak Grove Capital sold out of Pfizer (PFE) in Q2 2023, closing a stake of 5,400 shares — an estimated $220K sold.

Oak Grove Capital first reported a position in PFE in Q2 2021 and held it in 8 quarters. The position peaked at $1.66M in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

Oak Grove Capital reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
Oak Grove Capital sold 5,400 Pfizer shares in Q2 2023, an estimated $220K.
Oak Grove Capital first reported a position in Pfizer in Q2 2021 and held it in 8 quarters.
Oak Grove Capital's Pfizer position peaked at $1.66M in Q4 2021.
3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Oak Grove Capital's 13F filing for Q2 2023, filed 7 Aug 2023.